Literature DB >> 10847412

Planning factors for developing an enterprise-wide picture archiving and communication system maintenance program.

S Staley1, J Romlein, A K Chacko, R Wider.   

Abstract

Picture archiving and communication system (PACS) maintenance on an individual site basis has historically been a complex and costly challenge. With the advent of enterprise-wide PACS projects such as the Virtual Radiology Environment (VRE) project, the challenge of a maintenance program with even more complexities has presented itself. The approach of the project management team for the VRE project is not one of reactive maintenance, but one of highly proactive planning and negotiations, in hopes of capitalizing on the economies of scale of an enterprise-wide PACS maintenance program. A proactive maintenance program is one aspect of life-cycle management. As with any capital acquisition, life-cycle management may be used to manage the specific project aspects related to PACS. The purpose of an enterprise-wide warranty and maintenance life-cycle management approach is to maintain PACS at its maximum operational efficiency and utilization levels through a flexible, shared, yet symbiotic relationship between local, regional, and vendor resources. These goals include providing maximum operational performance levels on a local, regional, and enterprise basis, while maintaining acceptable costs and resource utilization levels. This goal must be achieved without negatively impacting point of care activities, regardless of changes to the clinical business environment.

Mesh:

Year:  2000        PMID: 10847412      PMCID: PMC3453255          DOI: 10.1007/bf03167674

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.056


  1 in total

1.  IT services in a completely digitized radiological department: value and benefit of an in-house departmental IT group.

Authors:  M Treitl; S Wirth; A Lucke; S Villain; J Rieger; K J Pfeifer; M Reiser
Journal:  Eur Radiol       Date:  2004-12-21       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.